Search

Your search keyword '"Rumsfeld, John S."' showing total 1,488 results

Search Constraints

Start Over You searched for: Author "Rumsfeld, John S." Remove constraint Author: "Rumsfeld, John S."
1,488 results on '"Rumsfeld, John S."'

Search Results

202. 2017 Roadmap for Innovation—ACC Health Policy Statement on Healthcare Transformation in the Era of Digital Health, Big Data, and Precision Health

203. Hospital Practice of Direct‐Home Discharge and 30‐Day Readmission After Transcatheter Aortic Valve Replacement in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (STS/ACC TVT) Registry

204. Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement

205. Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes

208. Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End‐Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization—An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program

209. The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association

212. Abstract 13384: Prognosis of Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries as Compared With Obstructive Coronary Disease

214. Gait Speed Predicts 30-Day Mortality After Transcatheter Aortic Valve Replacement Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

215. Colaboradores

216. Patient Selection for Diagnostic Coronary Angiography and Hospital-Level PCI Appropriateness: Insights from the NCDR®

217. Can We Predict Who Will Be Alive and Well After TAVR? Is That Useful to Individual Patients?

218. Chronic Kidney Disease Progression and Cardiovascular Outcomes Following Cardiac Catheterization—A Population‐Controlled Study

220. Variation in Hospital Risk–Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States

225. Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention

231. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program

234. Response to Letter Regarding Article, “Facility Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention: Insights on Short-Term Healthcare Value From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System (VA CART) Program”

235. Annual Outcomes With Transcatheter Valve Therapy

236. The National Cardiovascular Data Registry Voluntary Public Reporting Program

237. Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External Validation

238. Annual Outcomes With Transcatheter Valve Therapy

239. Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement

240. Colaboradores

241. Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States.

242. Achieving meaningful devices surveillance: from reaction to proaction

243. Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures

244. TCT-111 Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: Insights from the US TVT National Registry

249. Variation in performance measure criteria significantly affects cardiology practice rankings: Insights from the National Cardiovascular Data Registry's Practice Innovation and Clinical Excellence Registry

Catalog

Books, media, physical & digital resources